TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmbiotech Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
14,869
|
351
|
0 |
Financial expenses |
112
|
0 | |
Earnings before taxes |
4,193
|
1,403
|
-37 |
Total assets |
5,658
|
19,469
|
17,965 |
Current assets |
2,736
|
2,933
|
14,838 |
Current liabilities |
15
|
15,118
|
14,920 |
Equity capital |
59
|
127
|
67 |
- share capital |
22
![]() |
22
![]() |
22 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
1.0%
|
0.7%
|
0.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
28.2%
|
399.7% | |
Return on assets (ROA) |
7.8%
|
-0.2% | |
Current ratio |
18240.0%
|
19.4%
|
99.5% |
Return on equity (ROE) |
7106.8%
|
1104.7%
|
-55.2% |
Change turnover |
14,519
|
351 | |
Change turnover % | 4155% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.